新股孖展统计 | 8月8日

Group 1 - The core viewpoint of the article is that Silver Noble Pharmaceuticals-B (02591) is currently in the process of an IPO, attracting significant interest from investors [1] - As of August 8, a total of HKD 39.30325 billion has been lent to Silver Noble Pharmaceuticals by brokers including Futu, Huatai, and others [1] - The IPO has been oversubscribed by more than 576 times, indicating strong demand for the shares [1]